Management of drug-interaction alerts in community pharmacies

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 2, 2007, Pages 133-142

  Indermitte, J ^a   Beutler, M ^b   Bruppacher, R ^c   Meier, C R ^a,d   Hersberger, K E ^a,b,e  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Medicines Commission of Swiss Pharmacists   (Switzerland)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e NONE   (Switzerland)

Author keywords

Computer systems; Drug interactions; Pharmaceutical care

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CATION; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; MACROLIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHODIESTERASE V INHIBITOR; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; SALICYLIC ACID; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HUMAN; INTERVIEW; MALE; PATIENT CARE; PHARMACIST; PHARMACY; PRESCRIPTION; STUDENT; SWITZERLAND; UNSPECIFIED SIDE EFFECT;

CLINICAL PHARMACY INFORMATION SYSTEMS; COMMUNITY PHARMACY SERVICES; DRUG INTERACTIONS; HUMANS; INFORMATION MANAGEMENT; PATIENT EDUCATION; QUESTIONNAIRES; STUDENTS, PHARMACY; SWITZERLAND;

EID: 33947365965     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00802.x     Document Type: Article

References (29)

1. Becker ML, Kallewaard M, Caspers PW, Schalekamp T, Stricker BH (2005) Potential determinants of drug-drug interaction associated dispensing in community pharmacies. Drug Safety, 28, 371-378.
2. Halkin H, Katzir I, Kurman I, Jan J, Malkin BB (2001) Preventing drug interactions by online prescription screening in community pharmacies and medical practices. Clinical Pharmacology and Therapeutics, 69, 260-265.
3. Tamblyn R, Huang A, Perreault R et al. (2003) The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. Canadian Medical Association Journal, 169, 549-556.
4. Malone DC, Hutchins DS, Haupert H et al. (2005) Assessment of potential drug-drug interactions with a prescription claims database. American Journal of Health System Pharmacy, 62, 1983-1991.
5. Hazlet TK, Lee TA, Hansten PD, Horn JR (2001) Performance of community pharmacy drug interaction software. Journal of the American Pharmaceutical Association (Washington), 41, 200-204.
6. Hansten PD (2003) Drug interaction management. Pharmacy World & Science, 25, 94-97.
7. Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS (2003) Physicians' decisions to override computerized drug alerts in primary care. Archives of Internal Medicine, 163, 2625-2631.
8. Murphy JE, Forrey RA, Desiraju U (2004) Community pharmacists' responses to drug-drug interaction alerts. American Journal of Health System Pharmacy, 61, 1484-1487.
9. Chui MA, Rupp MT (2000) Evaluation of online prospective DUR programs in community pharmacy practice. Journal of Managed Care Pharmacy, 6, 200-204.
10. Magnus D, Rodgers S, Avery AJ (2002) GPs' views on computerized drug interaction alerts: questionnaire survey. Journal of Clinical Pharmacy and Therapeutics, 27, 377-382.
11. Indermitte J, Erba L, Beutler M, Bruppacher R, Haefeli WE, Hersberger KE (2007) Management of potential drug interactions in community pharmacies: a questionnaire based survey in Switzerland. European Journal of Clinical Pharmacology, (DOI: 10.1007/s00228-006-0237-5).
12. Jorgensen CK, Karlsmose B (1998) Validation of automated forms processing. A comparison of Teleform with manual data entry. Computers in Biology and Medicine, 28, 659-667.
13. E-mediat AG (2005) Pharmavista®. E-mediat AG, Schönbühl, Switzerland.
14. ABDA-Datenbank (2005) Werbe- und vertriebsgesellschaft deutscher apotheker mbH. Eschborn, Germany.
15. Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haefeli WE (2004) Drug interactions in primary care: impact of a new algorithm on risk determination. Clinical Pharmacology and Therapeutics, 76, 85-96.
16. Horn JR, Hansten PD (2004) Drug interaction classification systems. Pharmacy Times, 8, 60.
17. Smith WD, Hatton RC, Fann AL, Baz MA, Kaplan B (2005) Evaluation of drug interaction software to identify alerts for transplant medications. Annals of Pharmacotherapy, 39, 45-50.
18. Durieux P (2005) Electronic medical alerts - so simple, so complex. New England Journal of Medicine, 352, 1034-1036.
19. Horn JR, Hansten PD (2006) Making computerized screening work for you. Pharmacy Times, 2, 26.
20. Abarca J, Malone DC, Skrepnek GH et al. (2006) Community pharmacy managers' perception of computerized drug-drug interaction alerts. Journal of the American Pharmaceutical Association (Washington), 46, 148-153.
21. Peng CC, Glassman PA, Marks IR, Fowler C, Castiglione B, Good CB (2003) Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population. Journal of Managed Care Pharmacy, 9, 513-522.
22. Jankel CA, Fitterman LK (1993) Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Safety, 9, 51-59.
23. Gandhi TK, Weingart SN, Borus J et al. (2003) Adverse drug events in ambulatory care. New England Journal of Medicine, 348, 1556-1564.
24. Gurwitz JH, Field TS, Harrold LR et al. (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. Journal of the American Medical Association, 289, 1107-1116.
25. Egger T, Dormann H, Ahne G et al. (2003) Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs & Aging, 20, 769-776.
26. Horn JR, Hansten PD (2005) Of white swans, bigfoot and drug interactions. Pharmacy Times, 1, 62.
27. Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R (1996) Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. Canadian Medical Association Journal, 154, 1177-1184.
28. Hansten PD, Horn JR, Hazlet TK (2001) ORCA: OpeRational ClassificAtion of drug interactions. Journal of the American Pharmaceutical Association (Washington), 41, 161-165.
29. Indermitte J, Reber D, Beutler M, Bruppacher R, Hersberger KE (2006) Prevalence and patient awareness of selected potential drug interactions with self-medication. Journal of Clinical Pharmacy and Therapeutics, in press.